SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001000694-24-000031
Filing Date
2024-05-10
Accepted
2024-05-10 08:05:26
Documents
87
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nvax-20240331.htm   iXBRL 10-Q 930807
2 EX-10.1 nvax-20240331xexhibit101.htm EX-10.1 54333
3 EX-10.2 nvax-20240331xexhibit102.htm EX-10.2 356789
4 EX-10.3 nvax-20240331xexhibit103.htm EX-10.3 365877
5 EX-10.4 nvax-20240331xexhibit104.htm EX-10.4 380763
6 EX-31.1 nvax-20240331xex311.htm EX-31.1 10720
7 EX-31.2 nvax-20240331xex312.htm EX-31.2 11030
8 EX-32.1 nvax-20240331xex321.htm EX-32.1 5165
9 EX-32.2 nvax-20240331xex322.htm EX-32.2 5140
15 image_01a.jpg GRAPHIC 6067
16 image_02.jpg GRAPHIC 167226
17 image_0a.jpg GRAPHIC 127815
18 image_0b.jpg GRAPHIC 282
19 image_1.jpg GRAPHIC 700442
20 image_11a.jpg GRAPHIC 700442
21 image_12.jpg GRAPHIC 700442
22 nvax-20240331_g1.jpg GRAPHIC 202980
  Complete submission text file 0001000694-24-000031.txt   11104466

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvax-20240331.xsd EX-101.SCH 43573
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nvax-20240331_cal.xml EX-101.CAL 50610
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nvax-20240331_def.xml EX-101.DEF 274121
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nvax-20240331_lab.xml EX-101.LAB 592563
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvax-20240331_pre.xml EX-101.PRE 456464
91 EXTRACTED XBRL INSTANCE DOCUMENT nvax-20240331_htm.xml XML 689723
Mailing Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878
Business Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 24932936
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)